All News

Fatigue is something that everyone has experience with, but the fatigue of cancer is something unique that only patients and survivors understand and try to cope with.

From influential musician Little Richard passing away due to bone cancer to a dramatic drop in new cancer diagnoses as screenings have been postponed as a result of COVID-19, here are all the major updates happening in the cancer space this week.

The Food and Drug Administration approved the first new treatment option for Kaposi sarcoma in more than 20 years.

It is hard enough dealing with cancer as a survivor, but what happens when one of your parents is diagnosed with cancer too?

Researchers showed that integration of a comprehensive geriatric assessment with geriatrician-led management care improved quality of life for older adults with cancer.

“It’s never too late to quit smoking,” is the primary message of a new study that shows those who quit smoking have a survival benefit prior to a lung cancer diagnosis.   

“The intervention described in this abstract is important in that it provides clear and concrete activities — videoconference and coaching — caregivers can participate in to decrease anxiety and stress,” according to one expert.

Treatment with Lynparza in the maintenance setting extended overall survival by more than a year in women with platinum-sensitive relapsed ovarian cancer with BRCA1/2 mutations.

The Affordable Care Act allowed states to extend Medicaid coverage to more residents with low incomes or disabilities. Cancer death rates took a bigger dive in the states that utilized this provision, a nationwide study found.

Undertaking the cancer journey is a daunting task with its own challenges and tough questions to face, but that doesn't mean you have to do it alone.

In the first installment of CURE®’s inaugural webinar series, “Hear from the Experts: COVID-19 & Cancer Care for Patients,” Dr. Farukh Awan addressed concerns about the possibility of developing COVID-19 or any infection after a stem cell transplant to treat a blood cancer.

May marks Mental Health Awareness month, a crucial part of the healing required for patients on their cancer journey.

Further follow up of the CheckMate-214 trial continues to show the superior long-term outcomes of Opdivo and Yervoy in treatment of patients with advanced renal cell carcinoma.

Hope is a tenuous thing, but it is important to foster hope during the cancer journey even when the statistic don't feel hopeful.

All of us could choose to practice gratitude instead of judgment during these challenging times.

The Food and Drug Administration approved the first therapy to treat cancers with rearranged during transfection, or RET, gene alterations.

“(Feeling calm after my breast cancer diagnosis) had to do with the fact that I empowered myself with education.”

Lynparza and Avastin are now approved for patients with advanced ovarian cancer that carries a specific mutation and has responded to previous treatment with platinum-based chemotherapy plus Avastin.

Many cancer survivors are sad because the body has betrayed them. But remembering there is more to strength than just physicality can help cancer survivors.

From a 105-year-old cancer survivor recovering from COVID-19 to a 7-year-old finishing his last chemotherapy treatment for lymphoma and also beating COVID-19, here’s what’s making the headlines in the cancer landscape this week.

Patients with advanced renal cell carcinoma may soon have a new option in the novel combination of Opdivo (nivolumab) and Cabometyx (cabozantinib).

Obesity was associated with increased cardiovascular disease-related mortality and all-cause mortality, as well as potentially increased prostate cancer-specific mortality, in survivors of nonmetastatic prostate cancer.

Being a caregiver can be an isolating experience, but there is a wider community for all caregivers to lean on in their time of need.

In the first installment of CURE®’s inaugural webinar series, “Hear from the Experts: COVID-19 & Cancer Care for Patients,” Drs. Zainab Shahid, Farukh Awan and Ian Flinn addressed clinical trials that are underway to assess therapeutic approaches to COVID-19, including what role BTK inhibitors might play in treating the virus.

Tabrecta (capmatinib) will treat patients with metastatic non-small cell lung cancer that has a mutation leading to MET exon 14 skipping. The drug is the first targeted option for patients with lung cancer and this type of mutation.

In the first installment of CURE®’s inaugural webinar series, “Hear from the Experts: COVID-19 & Cancer Care for Patients”, Dr. Lee Greenberger addresses steps that the Leukemia and Lymphoma Society have taken to help patients with blood cancer during the COVID-19 pandemic.

People experiencing gastrointestinal symptoms or delays in colorectal cancer care should address these questions with their care team.

As we enter a new normal during the COVID-19 pandemic cancer survivors know all too well what that "new normal" means.